Patents for A61P 39 - General protective or antinoxious agents (19,019) |
---|
10/17/1990 | EP0392976A1 Monoclonal antibodies to tetracyclic compounds, processes for their production, and applications |
10/12/1990 | WO1990012599A1 Use of cobalt to enhance urinary copper excretion |
10/12/1990 | CA2031192A1 Use of cobalt to enhance urinary copper excretion |
10/10/1990 | CN1045974A Selective adenosine receptor compounds |
10/09/1990 | US4962127 Method for silicon reduction with dimercaptosuccinic acid (DMSA) |
10/08/1990 | WO1990012050A1 Chelants |
10/08/1990 | CA2051648A1 Chelants |
10/08/1990 | CA2014006A1 Monoclonal antibodies to tetracyclic compounds, processes for their production, and applications |
10/04/1990 | WO1990011083A1 Use of interleukin 2 to treat endotoxinemia |
10/04/1990 | DE3910011A1 Verwendung von interleukin-2 bei ausgedehnten bakteriellen infektionen The use of interleukin-2 for extended bacterial infections |
10/03/1990 | EP0390574A2 Compositions of phytic acid, and pharmaceutical uses thereof |
10/03/1990 | EP0390111A2 Selective adenosine receptor compounds |
10/03/1990 | EP0389975A1 Intranasal administration of physostigmine and arecoline |
09/28/1990 | CA2012192A1 Intranasal administration of physostigmine and arecoline |
09/26/1990 | EP0389370A1 19-Nor 3-keto steroids with an amine substituted 17-chain, method for their production and intermediates thereof. Their use as medicines and pharmaceutical composition containing them |
09/26/1990 | EP0389369A1 New 3-oxo-steroids with an amino substituted chain in position 17 a procedure for their production and intermediates of this procedure, their use as medicines and pharmaceutical preparations containing them |
09/26/1990 | EP0389180A1 Peptides and their use in therapy |
09/26/1990 | EP0388961A2 Inhibitors of aminoglycoside nephrotoxicity |
09/25/1990 | WO1990011143A1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same |
09/25/1990 | CA2030542A1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same |
09/23/1990 | CA2012459A1 Inhibitors of aminoglycoside nephrotoxicity |
09/19/1990 | EP0388241A1 Use of dimercaptosuccinic acid (DMSA) in treating silicon excess related disorders in blood or tissue |
09/12/1990 | EP0386452A1 Diphenyl heteroalkyl derivatives, their preparation and medicinal and cosmetic preparations prepared therefrom |
09/05/1990 | EP0385118A2 Use of compounds containing or binding sialic acid to neutralize bacterial toxins |
09/04/1990 | US4954339 Anticholesterol agents, sequestering |
08/16/1990 | EP0382180A2 Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it |
08/10/1990 | CA2009709A1 Derivatives of 3-pyroglutamyl-thiazolidine-4-carboxylic acid and their pharmacological properties |
08/10/1990 | CA2008042A1 Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom |
07/26/1990 | WO1990008134A1 Chelating agent derivatives |
07/18/1990 | EP0377739A1 Method of obtaining n-allyl-2-pyridinaldoxime bromide |
07/11/1990 | EP0377119A1 Agent for reducing adverse effects of table salt |
07/11/1990 | EP0376999A1 Method of reversing the side effects of epidural analgesics |
07/03/1990 | US4938949 Combatting side effects of anticancer drugs with dithiocarbamates |
06/28/1990 | WO1990006769A1 Antinephrotoxic perfusion solution |
06/28/1990 | DE3843241A1 Nephroprotektive infusionsloesung Nephroprotective infusion spoon |
06/07/1990 | CA2004769A1 Agent for reducing adverse effects of table salt |
06/06/1990 | EP0371598A1 Antidotes |
06/05/1990 | US4931554 Method of preparing a solid composition of lactulose, and composition so obtained |
05/23/1990 | EP0369715A1 Boehmite-type aluminium hydroxide, process for preparing same and phosphate ion adsorbent containing same as effective component |
05/23/1990 | EP0368972A1 Method of safely providing anesthesia or conscious sedation. |
05/17/1990 | WO1990004966A2 Chemoprevention of electrophilic damage by mercaptopurine analogs |
05/15/1990 | US4925478 Plant safening agents |
05/09/1990 | EP0367713A1 Antidote for blood anticoagulants based on factor VIII |
05/03/1990 | WO1990000594A3 Recombinant mycobacterial expression vehicles and uses therefor |
04/25/1990 | EP0364584A1 Antidote for organic phosphorus compound poisoning |
04/17/1990 | US4918094 Carboxamide derivatives of indoles and leucotriene antagonizing use thereof |
04/17/1990 | US4918064 Phenyl glycines for use in reducing neurotoxic injury |
03/22/1990 | WO1990002550A1 Treatment of damaged bone marrow and dosage units therefor |
03/20/1990 | US4910313 Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and process for the treatment of certain diseases in humans |
03/14/1990 | EP0357693A1 Molecular sieve arrangement. |
03/13/1990 | CA1266649A1 1-¬6-(2'-substituted-5',6',7',8'-tetrahydro-4'-oxo- quinazolino|-3,4-dihydro-6,7-disubstituted- isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
02/28/1990 | EP0355348A2 Superoxide dismutase composition |
02/21/1990 | EP0354920A1 Amino-9,10-secosteroids |
02/14/1990 | EP0354554A2 Anti-irritant and desensitizing compositions and methods of their use |
02/13/1990 | CA1265806A1 1-cyclohexyl-3,4-dihydroisoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
02/08/1990 | WO1990000853A2 Method of treating neurological disorders |
02/07/1990 | EP0354042A2 Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant |
01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
01/24/1990 | EP0351733A1 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders |
01/23/1990 | EP0294462A4 Protection against aminoglycoside-induced nephrotoxicity. |
01/23/1990 | CA1264748A1 .beta.-carboline-3-oxadiazolyl derivatives, method of preparing the same and_their use |
01/17/1990 | EP0190367B1 Benzo adh bdcinnoline compounds, process for their preparation, and mecidinal composition containing them |
01/10/1990 | EP0349545A1 New cardiodilatin fragment, process for preparing same and use thereof. |
12/28/1989 | WO1989012677A1 Superoxide dismutase analogs having novel binding properties |
12/28/1989 | WO1989012644A1 Endotoxin binding protein and uses thereof |
12/13/1989 | EP0346281A1 Carbamoylated hydroxamic-acid derivatives, and process for their preparation |
12/12/1989 | US4886791 Therapy of liver disorders |
12/05/1989 | CA1263651A1 Certain ring-fused pyrazolo ¬3,4-d|-pyridin-3-one derivatives |
11/30/1989 | WO1989011474A1 Method of obtaining n-allyl-2-pyridinaldoxime bromide |
11/28/1989 | US4883861 Cysteine-rich peptides having gamma-glutamic acid and beta-alanine units, a process for their preparation and their use |
11/22/1989 | CN1037349A Copolymers and superoxide dismutase modified with said copolymers |
11/15/1989 | EP0341558A2 Use and agent for diminishing the secondary effects of TNF |
11/02/1989 | WO1989010355A1 Derivatives of tryptophan as cck antagonists |
11/02/1989 | WO1989010127A1 Method of safely providing anesthesia or conscious sedation |
11/02/1989 | WO1989010125A1 Method of reversing the side effects of epidural analgesics |
11/02/1989 | WO1989010124A1 Antidote for organic phosphorus compound poisoning |
10/24/1989 | US4876282 1-Phenylalkylamines as selective serotonin uptake inhibitors |
10/18/1989 | EP0337765A2 Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists |
10/11/1989 | EP0336356A2 Derivatives of tryptophan as CCK antagonists |
10/03/1989 | US4871717 Peptides |
09/27/1989 | EP0334407A1 Method of preparing a solid composition of lactulose |
09/26/1989 | CA1260474A1 Benzoxazol- and benzothiazolamine derivatives |
09/08/1989 | WO1989007942A1 Method for protection from chemotherapeutic side effects |
08/30/1989 | EP0329879A1 Amino acids useful in hepatic disorders |
08/16/1989 | EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives |
08/10/1989 | WO1989006979A1 Paramagnetic compounds |
08/09/1989 | CN1034550A Compounds |
08/02/1989 | EP0326226A1 Paramagnetic compounds |
08/02/1989 | EP0326148A1 Human monoclonal antibody specific for Pseudomonas aeruginosa and hybrid cell lines |
07/25/1989 | US4851560 Inositol triphosphates |
07/18/1989 | CA1257597A1 Pharmacologically active 3-substituted indole derivatives |
07/13/1989 | WO1989006156A1 Molecular sieve arrangement |
07/13/1989 | WO1989006139A1 Reduction of side effects of cancer therapy |
07/11/1989 | US4847281 Method of medical treatment of addiction |
07/11/1989 | CA1257204A1 Botulinus toxin neutralizer |
06/29/1989 | WO1989005828A1 Compounds |
06/28/1989 | EP0322209A1 Compounds |
06/20/1989 | US4840964 For treatment of cardiovascular, nervous systems, and metabolism disorders in animals and humans |
06/20/1989 | US4840958 Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating patients having a toxic concentration of iron |
06/13/1989 | US4839387 Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it |